UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.36 Million Stock Holdings in Proto Labs, Inc. (NYSE:PRLB)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Proto Labs, Inc. (NYSE:PRLB) by 4.2% in the third quarter, Holdings Channel reports. The firm owned 80,189 shares of the industrial products company’s stock after purchasing an additional 3,247 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Proto Labs were worth $2,355,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Canada Pension Plan Investment Board bought a new position in shares of Proto Labs during the second quarter worth $37,000. Innealta Capital LLC acquired a new stake in Proto Labs during the 2nd quarter worth $40,000. KBC Group NV lifted its holdings in Proto Labs by 69.3% during the third quarter. KBC Group NV now owns 1,541 shares of the industrial products company’s stock worth $45,000 after acquiring an additional 631 shares in the last quarter. Meeder Asset Management Inc. acquired a new position in Proto Labs in the second quarter valued at about $80,000. Finally, Intech Investment Management LLC bought a new stake in shares of Proto Labs in the third quarter worth about $232,000. Institutional investors own 84.54% of the company’s stock.

Proto Labs Stock Performance

NYSE:PRLB opened at $43.59 on Friday. The stock has a 50-day simple moving average of $35.58 and a 200 day simple moving average of $32.27. Proto Labs, Inc. has a 52-week low of $25.75 and a 52-week high of $45.15. The company has a market cap of $1.07 billion, a PE ratio of 46.37 and a beta of 1.45.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings data on Friday, November 1st. The industrial products company reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.15. The company had revenue of $125.60 million for the quarter, compared to the consensus estimate of $121.38 million. Proto Labs had a net margin of 4.76% and a return on equity of 3.49%. The firm’s revenue was down 3.9% compared to the same quarter last year. During the same period last year, the company earned $0.31 earnings per share. On average, research analysts predict that Proto Labs, Inc. will post 0.84 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on PRLB. Cantor Fitzgerald reiterated an “overweight” rating and set a $40.00 price objective on shares of Proto Labs in a report on Monday, November 4th. Needham & Company LLC reaffirmed a “hold” rating on shares of Proto Labs in a research note on Friday, November 1st. Finally, Craig Hallum increased their price objective on shares of Proto Labs from $30.00 to $36.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Proto Labs presently has an average rating of “Moderate Buy” and a consensus target price of $40.33.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.